Morning Overview on MSN

A drug could become the first approved treatment for the muscle disease dermatomyositis

Adults living with dermatomyositis, a rare inflammatory disease that attacks muscles and skin, could soon have access to the ...
Business Wire

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Business Wire

AOM Infusion Designated a Limited Distribution Network Specialty Pharmacy for YIMMUGO® Immunoglobulin Replacement Therapy

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a ...
Everyday Health

IVIg to SCIg: Considerations When Switching Immunoglobulin Therapies for Primary Immunodeficiency

For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy (Ig) is a cornerstone of treatment. It helps prevent serious infections, reduces hospitalizations, and supports ...
Everyday Health

Making the Switch: Moving From IVIg to SCIg for CIDP

Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) includes IV infusion at a medical clinic, but now you can get a similar treatment through an injection or infusion at home.